The LMP1 gene isolated from Russian nasopharyngeal carcinoma has no 30-bp deletion

International Journal of Cancer

Volumn 91, Issue 6, 2001, Pages 815-821

  Hahn, Peter ^a   Novikova, Elena ^b   Scherback, Liana ^b   Janik, Constantin ^a   Pavlish, Oleg ^b   Arkhipov, Viktor ^b   Nicholls, John ^c   Müller Lantzsch, Nikolaus ^a   Gurtsevitch, Vladimir ^b   Grässer, Friedrich A ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

30 bp deletion; EBV; jun AP 1; LMP1; NFKB; NPC

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL TRANSFORMATION; EPSTEIN BARR VIRUS; FIBROBLAST; GENE DELETION; GENE EXPRESSION REGULATION; GENE ISOLATION; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NASOPHARYNX CARCINOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; STRAIN DIFFERENCE; TUMOR GROWTH;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; FEMALE; GENE DELETION; GERMANY; HUMANS; LUCIFERASES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NASOPHARYNGEAL NEOPLASMS; NF-KAPPA B; PAROTID NEOPLASMS; POLYMERASE CHAIN REACTION; RUSSIA; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR CELLS, CULTURED; VARIATION (GENETICS); VIRAL MATRIX PROTEINS;

EID: 0035869653     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200002)9999:9999<::AID-IJC1122>3.0.CO;2-W     Document Type: Article

References (21)

1. Epstein-Barr Virus
2. Epstein-Barr Virus and its replication
3. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade
4. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins
5. Functional analysis of different LMP1 proteins isolated from Epstein-Barr virus-positive carriers
6. The molecular epidemiology and evolution of Epstein-Barr virus: Sequence variation and genetic recombination in the latent membrane protein-1 gene
7. Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus(EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma
8. Prevalence of mutations and 30-bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese
9. Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: Identification of 4 variants among wild-type EBV isolates
10. High prevalence of a 30-base pair deletion and single-base mutations within the carboxy terminal end of the LMP1 oncogene of Epstein-Barr virus in the Japanese population
11. Deletion variants within the NF-kappa B activation domain of the LMP1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations
12. Sequence variation in the Epstein-Barr virus latent membrane protein 1
13. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma
14. Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissues identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population
15. Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong
16. The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes
17. Epstein-Barr-virus-associated gastric cancer in Russia
18. A new lytic antibody, 7D6, detects Epstein-Barr virus dUTPase in nonkeratinizing undifferentiated nasopharyngeal carcinomas
19. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
20. The residues between the 2 transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation
21. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains